Chandra Vargeese
Chief Tech/Sci/R&D Officer at WAVE LIFE SCIENCES LTD.
Net worth: 456 680 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Jörg Reinhardt | M | 68 | 40 years | |
| Christian Henry | M | 56 | 8 years | |
| Anne-Marie Li-Kwai-Cheung | F | - | 2 years | |
| Paul Bolno | M | 50 | 11 years | |
| Tom Glocer | M | 63 | 17 years | |
| Bill Winters | M | 62 | 11 years | |
| Aik Na Tan | F | 53 | 4 years | |
| Kyle Moran | M | 54 | 10 years | |
| Ken Takanashi | M | 60 | 12 years | |
| Heidi Wagner | F | 59 | 5 years | |
| Charles Sawyers | M | 65 | 11 years | |
| Peter Kolchinsky | M | 47 | 9 years | |
| Gregory Verdine | M | 65 | 12 years | |
| Adrian Rawcliffe | M | 52 | 7 years | |
| Mark Corrigan | M | 66 | 5 years | |
| V. U. Reddy | M | - |
Indian Institute of Science
| 36 years |
| Charlotte Pamer-Wieser | M | - | 13 years | |
| Linda K. Rockett | F | - | 8 years | |
| Christopher Francis | M | 46 | 10 years | |
| Kate Rausch | F | - | - | |
| Alicia Suter | F | - | 2 years | |
| Simon Brown | M | - | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Howard Robin | M | 71 |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 5 years |
| Rolf M. Zinkernagel | M | 80 | 15 years | |
| Takeshi Wada | M | 63 | 5 years | |
| Chris Christoffersen | M | 86 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 10 years |
| Wendelin Wiedeking | M | 72 | 11 years | |
| Craig Thompson | M | 71 | 10 years | |
| David Gaiero | M | 45 | 3 years | |
| Amy Pott | F | 47 | 2 years | |
| Kenneth Bartizal | M | 72 | 20 years | |
| Robert Iannone | M | 57 | 6 years | |
| Keith Regnante | M | 54 | 4 years | |
| José Juves | M | - | - | |
| Dirk van de Put | M | 63 | 1 years | |
| Enrico Cipro Vanni | M | 73 | - | |
| Susanne Antonie Schaffert | M | 57 | 2 years | |
| Shannon Klinger | M | 53 | 10 years | |
| Kim Stratton | F | 62 | 3 years | |
| Leslie Brun | M | 72 | 13 years | |
| Dimitri Azar | M | 65 | 7 years | |
| Ismail Kola | M | 67 | 4 years | |
| Patrick Mahaffy | M | 61 |
NeXstar Pharmaceuticals, Inc.
 NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | 6 years |
| Masaharu Tanaka | M | 71 | 3 years | |
| Richard Henriques | M | 68 | 27 years | |
| Barry A. Polisky | M | 78 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 6 years |
| Bharatt Chowrira | M | 59 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 15 years |
| Verena A. Briner | M | 72 | 3 years | |
| Michael Panzara | M | 57 | 6 years | |
| David Anstice | M | 75 | 5 years | |
| William Brody | M | 80 | - | |
| R. Greer | M | 65 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 6 years |
| Nassim Usman | M | 64 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 13 years |
| Daniel Vasella | M | 70 | 17 years | |
| Alexandre F. Jetzer-Chung | M | 83 | 15 years | |
| Judith Klimovsky | M | 67 | 8 years | |
| Robert Meyer | M | 65 | 6 years | |
| Timothy Murphy | M | 56 | 4 years | |
| Emmanuel Dulac | M | 55 | 8 years | |
| Adele D. Ambrose | F | 67 | - | |
| Lu Amy Sun | M | 67 | 7 years | |
| William Ludlam | M | 59 | 3 years | |
| Larry P. Allgaier | M | - | 6 years | |
| Liu Hui | M | 51 | 6 years | |
| Yao Lee | M | 54 | 3 years | |
| Laurent Sigismondi | M | 48 | 4 years | |
| Rafael Torgovicky | M | - | 2 years | |
| Parisa Zamiri | M | 59 | 8 years | |
| Yong Qing Luo | M | 54 | 2 years | |
| Mauro Ghilardi | M | 57 | 9 years | |
| Maude Tessier | M | 46 | 6 years | |
| Pascal Qian | M | 56 | 6 years | |
| Christian Mandl | M | - | 6 years | |
| Moran ben David | F | - | 2 years | |
| Alison Armour | M | 60 | 4 years | |
| Jonathan Peacock | M | 66 | 5 years | |
| Royston Glasspool | M | 61 | 10 years | |
| Janelle Anderson | M | 51 | 6 years | |
| Peter Kim | M | 65 | 5 years | |
| Anthony Adam Rosenberg | M | 71 | 3 years | |
| David Mauro | M | 59 | 7 years | |
| Judy Lewent | F | 75 | 27 years | |
| Peter Kellogg | M | 67 | 7 years | |
| Peter D. Löscher | M | 66 | 1 years | |
| Thomas Werlen | M | - | 5 years | |
| Graeme Bell | M | 57 | 2 years | |
| Raymond F. Kerins | M | - | 1 years | |
| François Martelet | M | 64 | 2 years | |
| Paul van Arkel | M | - | - | |
| Virginia Orndorff | F | 74 |
NeXstar Pharmaceuticals, Inc.
NeXstar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NeXstar Pharmaceuticals, Inc. was a commercial biopharmaceutical company engaged in the discovery, development, manufacture and marketing of proprietary pharmaceutical products to treat life-threatening and other serious diseases. The firm was located in Boulder, CO. | 4 years |
| Ludwig Hantson | M | 61 | 9 years | |
| Ray Hill | M | 79 | 18 years | |
| Mark Stejbach | M | 61 | 21 years | |
| Carole A. Sable | M | 62 | 12 years | |
| Silvana Battaglia | F | 56 | 10 years | |
| Michael Willi | M | 58 | 9 years | |
| Ginger Gregory | M | 56 | 7 years | |
| Harry Sacks | M | - | - | |
| Peter Elam | M | - | 8 years | |
| May Han | M | - | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 41 | 41.00% |
| United States | 36 | 36.00% |
| Singapore | 22 | 22.00% |
| India | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Chandra Vargeese
- Personal Network
